Physicians’ attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patients

We investigated factors that physicians consider of most importance in the selection of second line tyrosine kinase inhibitors treatments (TKIs) in chronic myeloid leukemia patients (CML). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12955-017-0788-4) contains supp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Health Qual Life Outcomes
Hlavní autoři: Breccia, Massimo, Baccarani, Michele, Rosti, Gianantonio, Cottone, Francesco, Cannella, Laura, Guilhot, François, Vignetti, Marco, Efficace, Fabio
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Letter to the Editor
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648464/
https://ncbi.nlm.nih.gov/pubmed/29047379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-017-0788-4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky